ERK2 C-Term Blocking Peptide

ERK2 C-Term Blocking Peptide
SKU
ROC000-001-GP1
Packaging Unit
50 µg
Manufacturer
Rockland

Availability: loading...
Price is loading...
Application Note: ERK2 N-term blocking peptide is suitable as a control for polyclonal or monoclonal Anti-ERK2 in immunological assays.

Concentration Value: 1.0 mg/mL

Western Blot Dilution: 50ng

General Disclaimer Note: This product is for research use only and is not intended for therapeutic or diagnostic applications. Please contact a technical service representative for more information. All products of animal origin manufactured by Rockland Immunochemicals are derived from starting materials of North American origin. Collection was performed in United States Department of Agriculture (USDA) inspected facilities and all materials have been inspected and certified to be free of disease and suitable for exportation. All properties listed are typical characteristics and are not specifications. All suggestions and data are offered in good faith but without guarantee as conditions and methods of use of our products are beyond our control. All claims must be made within 30 days following the date of delivery. The prospective user must determine the suitability of our materials before adopting them on a commercial scale. Suggested uses of our products are not recommendations to use our products in violation of any patent or as a license under any patent of Rockland Immunochemicals, Inc. If you require a commercial license to use this material and do not have one, then return this material, unopened to: Rockland Inc., P.O. BOX 5199, Limerick, Pennsylvania, USA.

Physical State: Lyophilized

Purity and Specificity: Purity was determined to be greater than 95% specific peptide by analysis by HPLC and by reducing and non-reducing SDS-PAGE.

Background: Mitogen activated protein kinase 1, also known as MAPK1, ERK, or ERK2, is an integral component of the MAP kinase cascade that regulates cell growth and differentiation. ERK1 and ERK2 are activated by MEK1 and MEK2 in the B-raf signaling pathway resulting in its translocation to the nucleus where it phosphorylates nuclear targets. Human ERK1 and ERK2 are 84% identical in sequence and share common functionality in cells. ERK2 is ideal for investigators involved in Neuroscience, Cell Signaling and Cancer Research.

Low Endotoxin: No

Other: Dot Blot
More Information
SKU ROC000-001-GP1
Manufacturer Rockland
Manufacturer SKU 000-001-GP1
Package Unit 50 µg
Quantity Unit STK
Conjugate Unconjugated
Product information (PDF) Download
MSDS (PDF)
×